• Health & Medicine

Ovarian cancer drug will be offered earlier to NHS patients in England

A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England. A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England.

26 July 2019

• Health & Medicine

Second breast cancer treatment combo added to England's Cancer Drugs Fund

Some patients with advanced breast cancer will now have access to a new drug combo on the NHS in England – after the NICE reversed its initial decision Some patients with advanced breast cancer will now have access to a new drug combo on the NHS in England – after the NICE reversed its initial decision

17 July 2019

• Health & Medicine

Three new cancer treatments available for NHS patients in Scotland

A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland. A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.

11 July 2019

• Health & Medicine

New skin cancer immunotherapy added to NHS England’s Cancer Drugs Fund

A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England. A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England.

4 July 2019

• Health & Medicine

The first complete picture of how long it takes to diagnose cancer in England

Researchers have gathered the most complete picture of how long people wait for a cancer diagnosis in England. And there's huge variation between referrals. Researchers have gathered the most complete picture of how long people wait for a cancer diagnosis in England. And there's huge variation between referrals.

30 June 2019

• Health & Medicine

NHS to ‘fast track’ new personalised cancer medicines – but it’s not ready quite yet

NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients. NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.

19 June 2019

• Health & Medicine

NICE U-turn opens up new treatment option for some adults with leukaemia

Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England. Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.

19 June 2019

• Health & Medicine

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland. One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

12 June 2019

• Health & Medicine

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment. A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.

17 May 2019

• Health & Medicine

Prostate cancer MRI scans: is the NHS ready?

All men with suspected prostate cancer should be offered a specialist MRI scan, before a biopsy. That's the new recommendation, but is the NHS ready? All men with suspected prostate cancer should be offered a specialist MRI scan, before a biopsy. That's the new recommendation, but is the NHS ready?

9 May 2019

• Health & Medicine

Kidney cancer immunotherapy combo approved for NHS use in England

A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England. A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.

5 April 2019

• Health & Medicine

Linking cancer drug prices to treatment success could speed up approvals. But what do patients consider success?

With NHS budgets stretched, it’s critical that cancer drugs offer value for money. We’ve teamed up with the Greater Manchester Health and Social Care Partnership to investigate a different approach to drug pricing. With NHS budgets stretched, it’s critical that cancer drugs offer value for money. We’ve teamed up with the Greater Manchester Health and Social Care Partnership to investigate a different approach to drug pricing.

21 February 2019